Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages 1149-1161

  Hughes, David J ^a   Fedirko, Veronika ^b   Jenab, Mazda ^c   Schomburg, Lutz ^d   Méplan, Catherine ^e   Freisling, Heinz ^c   Bueno De Mesquita, H Bas ^f,g,h   Hybsier, Sandra ^d   Becker, Niels Peter ^d   Czuban, Magdalena ^d   Tjønneland, Anne ⁱ   Outzen, Malene ⁱ   Boutron Ruault, Marie Christine ^j,k,l   Racine, Antoine ^j,k,l   Bastide, Nadia ^j,k,l   Kühn, Tilman ^m   Kaaks, Rudolf ^m   Trichopoulos, Dimitrios ^n,o,p   Trichopoulou, Antonia ^o,p   Lagiou, Pagona ^n,o,q   Panico, Salvatore ^r   Peeters, Petra H ^g,h   Weiderpass, Elisabete ^s,t,u,v   Skeie, Guri ^s   Dagrun, Engeset ^s   Chirlaque, Maria Dolores ^w,x   Sánchez, Maria Jose ^x,y   Ardanaz, Eva ^x,z   Ljuslinder, Ingrid ^aa   Wennberg, Maria ^aa   Bradbury, Kathryn E ^ab   Vineis, Paolo ^h,ac   Naccarati, Alessio ^ac   Palli, Domenico ^ad   Boeing, Heiner ^ae   Overvad, Kim ^af   Dorronsoro, Miren ^x,ag   Jakszyn, Paula ^ah   Cross, Amanda J ^h   Quirós, Jose Ramón ^ai   Stepien, Magdalena ^c   Kong, So Yeon ^c   Duarte Salles, Talita ^c   Riboli, Elio ^h   Hesketh, John E ^e   more..

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b EMORY UNIVERSITY   (United States)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^j CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^k UNIVERSITÉ PARIS SACLAY   (France)

^l IGR   (France)

^m GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁿ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^o BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^p HELLENIC HEALTH FOUNDATION   (Greece)

^q UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^r UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^s UNIVERSITY OF TROMSØ   (Norway)

^t CANCER REGISTRY OF NORWAY   (Norway)

^u KAROLINSKA INSTITUTE   (Sweden)

^v FOLKHÄLSAN RESEARCH CENTER   (Finland)

^w Murcia Regional Health Authority   (Spain)

^x CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^y Hospital Universitario de Granada   (Spain)

^z INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^aa UMEÅ UNIVERSITY   (Sweden)

^ab UNIVERSITY OF OXFORD   (United Kingdom)

^ac Human Genetics Foundation (HuGeF)   (Italy)

^ad CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^ae GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^af AARHUS UNIVERSITY   (Denmark)

^ag BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^ah CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ai PUBLIC HEALTH DIRECTORATE   (Spain)

more..

Author keywords

Colorectal neoplasms; Prospective cohort; Selenium; Selenium status; Selenoprotein P

Indexed keywords

SELENIUM; SELENOPROTEIN P; TUMOR MARKER;

ADULT; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; EUROPE; FEMALE; FISH; FRUIT; HUMAN; MAJOR CLINICAL STUDY; MALE; PROCESSED MEAT; RED MEAT; SELENIUM BLOOD LEVEL; SEX DIFFERENCE; SHELLFISH; SMOKING; VEGETABLE; AGED; BLOOD; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; NUTRITIONAL STATUS; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SPECTROMETRY;

ADULT; AGED; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SELENIUM; SELENOPROTEIN P; SPECTROMETRY, X-RAY EMISSION;

EID: 84918794841     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29071     Document Type: Article

References (50)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-403.
2. Cappellani A, Zanghi A, Di Vita M, et al. Strong correlation between diet and development of colorectal cancer. Front Biosci (landmark edition) 2013;18:190-8.
3. Bellinger FP, Raman AV, Reeves MA, et al. Regulation and function of selenoproteins in human disease. Biochem J 2009;422:11-22.
4. Hatfield DL, Tsuji PA, Carlson BA, et al. Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem Sci 2014;39:112-20.
5. Rayman MP. Food-chain selenium and human health: emphasis on intake. Br J Nutr 2008;100:254-68.
6. Johnson CC, Fordyce FM, Rayman MP. Symposium on 'Geographical and geological influences on nutrition': factors controlling the distribution of selenium in the environment and their impact on health and nutrition. Proc Nutr Soc 2010;69:119-32.
7. Rayman MP. Selenoproteins and human health: insights from epidemiological data. Biochim Biophys Acta 2009;1790:1533-40.
8. Fairweather-Tait SJ, Bao Y, Broadley MR, et al. Selenium in human health and disease. Antioxid Redox Signal 2011;14:1337-83.
9. Bonelli L, Puntoni M, Gatteschi B, et al. Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A doubleblind randomized trial. J Gastroenterol 2013;48:698-705.
10. Wallace K, Byers T, Morris JS, et al. Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested casecontrol study. Cancer Epidemiol Biomarkers Prev 2003;12:464-7.
11. Jacobs ET, Jiang R, Alberts DS, et al. Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst 2004;96:1669-75.
12. Peters U, Chatterjee N, Church TR, et al. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev 2006;15:315-20.
13. Clark LC, Combs GF, Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-63.
14. Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002;11:630-9.
15. Meplan C, Hesketh J. The influence of selenium and selenoprotein gene variants on colorectal cancer risk. Mutagenesis 2012;27:177-86.
16. Vinceti M, Crespi CM, Malagoli C, et al. Friend or foe? The current epidemiologic evidence on selenium and human cancer risk. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2013;31:305-41.
17. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 2009;301:39-51.
18. Takata Y, Kristal AR, King IB, et al. Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2011;20:1822-30.
19. Steinbrenner H, Speckmann B, Sies H. Toward understanding success and failures in the use of selenium for cancer prevention. Antioxid Redox Signal 2013;19:181-91.
20. Waters DJ, Chiang EC, Cooley DM, et al. Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women. Mutat Res 2004;551:91-107.
21. Combs GF, Jr. Selenium in global food systems. Br J Nutr 2001;85:517-47.
22. Combs GF, Jr, Jackson MI, Watts JC, et al. Differential responses to selenomethionine supplementation by sex and genotype in healthy adults. Br J Nutr 2012;107:1514-25.
23. Riese C, Michaelis M, Mentrup B, et al. Seleniumdependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues. Endocrinology 2006;147:5883-92.
24. Schomburg L, Schweizer U. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim Biophys Acta 2009;1790:1453-62.
25. Ashton K, Hooper L, Harvey LJ, et al. Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr 2009;89:2025S-39S.
26. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European prospective investigation into cancer and nutrition. Int J Epidemiol 1997;26(Suppl 1):S6-14.
27. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
28. Hoeflich J, Hollenbach B, Behrends T, et al. The choice of biomarkers determines the selenium status in young German vegans and vegetarians. Br J Nutr 2010;104:1601-4.
29. Hollenbach B, Morgenthaler NG, Struck J, et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008;22:24-32.
30. Steinbrecher A, Meplan C, Hesketh J, et al. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev 2010;19:2958-68.
31. Knol MJ, Vandenbroucke JP, Scott P, et al. What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol 2008;168:1073-81.
32. Burk RF, Hill KE. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 2005;25:215-35.
33. Hurst R, Armah CN, Dainty JR, et al. Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2010;91:923-31.
34. Xia Y, Hill KE, Li P, et al. Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects. Am J Clin Nutr 2010;92:525-31.
35. Goyal A, Terry MB, Siegel AB. Serum antioxidant nutrients, vitamin A, and mortality in U. S. Adults. Cancer Epidemiol Biomarkers Prev 2013;22:2202-11.
36. Schomburg L, Kohrle J. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol Nutr Food Res 2008;52:1235-46.
37. Combs GF, Jr, Watts JC, Jackson MI, et al. Determinants of selenium status in healthy adults. Nutr J 2011;10:75.
38. Lloyd B, Lloyd RS, Clayton BE. Effect of smoking, alcohol, and other factors on the selenium status of a healthy population. J Epidemiol Community Health 1983;37:213-7.
39. Fortmann SP, Burda BU, Senger CA, et al. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U. S. preventive services task force. Ann Intern Med 2013;159:824-34.
40. Michaelis M, Gralla O, Behrends T, et al. Selenoprotein P in seminal fluid is a novel biomarker of sperm quality. Biochem Biophys Res Commun 2014;443:905-10.
41. Meplan C, Crosley LK, Nicol F, et al. Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J 2007;21:3063-74.
42. Meplan C, Crosley LK, Nicol F, et al. Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. Am J Clin Nutr 2008;87:1019-27.
43. Meplan C, Dragsted LO, Ravn-Haren G, et al. Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer risk. PloS One 2013;8:e73316.
44. Meplan C, Nicol F, Burtle BT, et al. Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status. Antioxid Redox Signal 2009;11:2631-40.
45. Meplan C, Hughes DJ, Pardini B, et al. Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 2010;31:1074-9.
46. Slattery ML, Lundgreen A, Welbourn B, et al. Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer. PloS One 2012;7:e37312.
47. Zhou X, Smith AM, Failla ML, et al. Estrogen status alters tissue distribution and metabolism of selenium in female rats. J Nutr Biochem 2012;23:532-8.
48. Norat T, Bingham S, Ferrari P, et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 2005;97:906-16.
49. O'Morain CA, Van Cutsem E, Spicak J, et al. European initiatives in colorectal cancer screening. Eur J Gastroenterol Hepatol 2011;23:201-3.
50. Rayman MP, Stranges S. Epidemiology of selenium and type 2 diabetes: can we make sense of it? Free Radic Biol Med 2013;65:1557-64.